IGNITE NEWS DESK
“We welcome your comments”
New indications approved by FDA for topical treatment of tick infestation in cats Merck Animal Health has announced the new label indication for both fluralaner topical solution (Bravecto) and fluralaner and moxidectin topical solution (Bravecto Plus) for the treatment and control of Asian long-horned tick infestations in cats. Both products are the first US products labeled for both the treatment and control of Asian long-horned tick infestations. The Asian long-horned tick is an invasive ixodid tick that is native to Japan, China, eastern Russia, and Korea. As of December 2021, the species has been located across more than a third of the United States, according to Merck. These ticks have the potential to quickly become an important tick species within pet populations and are known for carrying various viral, bacterial, and protozoal agents.